{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:34:13Z","timestamp":1792798453304,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016525","name":"Florida Agricultural Experiment Station","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016525","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011944","name":"School of Public Health, University of California Berkeley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jaip.2020.09.063","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T02:23:29Z","timestamp":1602555809000},"page":"1133-1141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":405,"title":["Chronic Rhinosinusitis with Nasal Polyps and Asthma"],"prefix":"10.1016","volume":"9","author":[{"given":"Tanya M.","family":"Laidlaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Mullol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine M.","family":"Woessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda P.","family":"Mannent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.09.063_bib1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic rhinosinusitis in Europe\u2014an underestimated disease. A GA2LEN study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib2","first-page":"1","article-title":"Summary health statistics for U.S. adults: National Health Interview Survey, 2008","volume":"242","author":"Pleis","year":"2009","journal-title":"Vital Health Stat 10"},{"issue":"Suppl S29","key":"10.1016\/j.jaip.2020.09.063_bib3","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"issue":"Suppl 1","key":"10.1016\/j.jaip.2020.09.063_bib4","first-page":"S22","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis","volume":"6","author":"Orlandi","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.09.063_bib5","series-title":"A\u00a0cross-sectional population-based survey of the prevalence, disease burden, and characteristics of the US adult population with symptoms of chronic rhinosinusitis (CRS). Poster presented at: 62nd Annual Meeting of the American Rhinologic Society","author":"Palmer","year":"2016"},{"key":"10.1016\/j.jaip.2020.09.063_bib6","first-page":"1","article-title":"Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden","volume":"14","author":"Beule","year":"2015","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.09.063_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1398-9995.2011.02709.x","article-title":"Asthma in adults and its association with chronic rhinosinusitis: The GA2LEN survey in Europe","volume":"67","author":"Jarvis","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib8","first-page":"45","article-title":"Nasal polyps in patients with asthma: prevalence, impact and management challenges","volume":"9","author":"Langdon","year":"2016","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib9","doi-asserted-by":"crossref","first-page":"e0127228","DOI":"10.1371\/journal.pone.0127228","article-title":"Airway inflammation in chronic rhinosinusitis with nasal polyps and asthma: the united airways concept further supported","volume":"10","author":"H\u00e5kansson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2020.09.063_bib10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/ajrccm.164.5.2006082","article-title":"Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa","volume":"164","author":"Braunstahl","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.09.063_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1067\/mai.2001.113046","article-title":"Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways","volume":"107","author":"Braunstahl","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0889-8561(03)00104-8","article-title":"Allergic rhinitis, rhinosinusitis, and asthma: one airway disease","volume":"24","author":"Bachert","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"issue":"Suppl 86","key":"10.1016\/j.jaip.2020.09.063_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1067\/mai.2002.122458","article-title":"Chronic sinusitis in severe asthma is related to sputum eosinophilia","volume":"109","author":"ten Brinke","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4193\/RHINOL\/18.006","article-title":"Progression from nasal polyps to adult-onset asthma: a different process from atopic march?","volume":"1","author":"Wu","year":"2018","journal-title":"Rhinology Online"},{"key":"10.1016\/j.jaip.2020.09.063_bib16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.09.063_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1398-9995.2005.00688.x","article-title":"Prevalence of nasal polyposis in France: a cross-sectional, case-control study","volume":"60","author":"Klossek","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2500\/108854196778662255","article-title":"The clinical relationship of nasal polyps to asthma","volume":"17","author":"Larsen","year":"1996","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2020.09.063_bib19","series-title":"C.A. Akdis, I. Agache (eds.) Global Atlas of Asthma","first-page":"92","article-title":"Aspirin exacerbated respiratory disease","author":"Kowalski","year":"2013"},{"issue":"Suppl 2","key":"10.1016\/j.jaip.2020.09.063_bib20","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1136\/thorax.55.suppl_2.S42","article-title":"Clinical features and diagnosis of aspirin induced asthma","volume":"55","author":"Szczeklik","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2020.09.063_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.iac.2012.11.002","article-title":"Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease","volume":"33","author":"Mullol","year":"2013","journal-title":"Immunology Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2020.09.063_bib22","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/all.12629","article-title":"NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity","volume":"70","author":"Morales","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cea.12472","article-title":"Pathogenesis of nasal polyposis","volume":"45","author":"Hulse","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMcibr1514013","article-title":"Aspirin-exacerbated respiratory disease\u2014new prime suspects","volume":"374","author":"Laidlaw","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.09.063_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)\u2014a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.iac.2016.06.004","article-title":"AERD as an endotype of chronic rhinosinusitis","volume":"36","author":"Stevens","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2020.09.063_bib27","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1097\/MLG.0b013e318184e216","article-title":"Predictors of olfactory dysfunction in patients with chronic rhinosinusitis","volume":"118","author":"Litvack","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.09.063_bib28","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaci.2010.07.007","article-title":"Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma","volume":"126","author":"Bachert","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/194589240401800105","article-title":"Objective assessment of lower airway involvement in chronic rhinosinusitis","volume":"18","author":"Ragab","year":"2004","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaip.2020.09.063_bib30","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1365-2222.2011.03793.x","article-title":"Airway dysfunction in nasal polyposis: a spectrum of asthmatic disease?","volume":"41","author":"Williamson","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.resp.2014.08.017","article-title":"Tracheal section is an independent predictor of asthma in patients with nasal polyposis","volume":"203","author":"Bokov","year":"2014","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.jaip.2020.09.063_bib32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1398-9995.2006.01228.x","article-title":"Oxidative stress in nonallergic nasal polyps associated with bronchial hyperresponsiveness","volume":"61","author":"Cheng","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jaci.2003.12.009","article-title":"Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis","volume":"113","author":"Tsicopoulos","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib34","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.anai.2018.02.005","article-title":"Age-related prevalence of chronic rhinosinusitis and nasal polyps and their relationships with asthma onset","volume":"120","author":"Won","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib35","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jaip.2018.10.016","article-title":"The Severe Asthma Network in Italy: findings and perspectives","volume":"7","author":"Heffler","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"Suppl 57","key":"10.1016\/j.jaip.2020.09.063_bib36","first-page":"P3448","article-title":"Chronic rhinosinusitis with and without nasal polyps and rhinitis in adult asthma. Frequency distribution and relationship with asthma control and severity (the IRIS-ASMA study)","volume":"42","author":"Castillo","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.09.063_bib37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1165\/rcmb.2015-0207RC","article-title":"Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling","volume":"53","author":"Cho","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaip.2020.09.063_bib38","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jaci.2013.02.002","article-title":"Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis","volume":"131","author":"Tan","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4193\/Rhino09.095","article-title":"Comparative clinical and airway inflammatory features of asthmatics with or without polyps","volume":"48","author":"Bilodeau","year":"2010","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.09.063_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12948-018-0103-x","article-title":"Comorbidities are associated with different features of severe asthma","volume":"16","author":"Novelli","year":"2018","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1939-4551-7-25","article-title":"ICON: chronic rhinosinusitis","volume":"7","author":"Bachert","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2020.09.063_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4168\/aair.2017.9.4.299","article-title":"Emerging endotypes of chronic rhinosinusitis and its application to precision medicine","volume":"9","author":"Kim","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2020.09.063_bib43","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1164\/rccm.201412-2278OC","article-title":"Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease","volume":"192","author":"Stevens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.09.063_bib44","doi-asserted-by":"crossref","first-page":"e2998","DOI":"10.1097\/MD.0000000000002998","article-title":"Altered Th17\/Treg ratio in nasal polyps with distinct cytokine profile: association with patterns of inflammation and mucosal remodeling","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2020.09.063_bib45","doi-asserted-by":"crossref","first-page":"e82373","DOI":"10.1371\/journal.pone.0082373","article-title":"The development of nasal polyp disease involves early nasal mucosal inflammation and remodelling","volume":"8","author":"Meng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2020.09.063_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2012.02.046","article-title":"Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps","volume":"130","author":"Takabayashi","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/iid3.161","article-title":"Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps","volume":"5","author":"Poposki","year":"2017","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaip.2020.09.063_bib48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaci.2013.02.003","article-title":"Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps","volume":"132","author":"Takabayashi","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib49","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jaci.2013.04.005","article-title":"Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis","volume":"132","author":"Nagarkar","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-pathol-052016-100401","article-title":"Immunopathogenesis of chronic rhinosinusitis and nasal polyposis","volume":"12","author":"Schleimer","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jaip.2020.09.063_bib51","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cea.12462","article-title":"Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia","volume":"45","author":"Ho","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib52","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.2500\/ajra.2010.24.3436","article-title":"Synergistic induction of thymic stromal lymphopoietin by tumor necrosis factor alpha and Th2 cytokine in nasal polyp fibroblasts","volume":"24","author":"Nonaka","year":"2010","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2020.09.063_bib54","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jaci.2007.10.025","article-title":"Epithelium dysfunction in asthma","volume":"120","author":"Holgate","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cea.12880","article-title":"Revisiting type 2-high and type 2-low airway inflammation in asthma: current knowledge and therapeutic implications","volume":"47","author":"Robinson","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib56","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib57","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/17476348.2017.1381564","article-title":"The role of upper airway pathology as a co-morbidity in severe asthma","volume":"11","author":"Licari","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaip.2020.09.063_bib58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000479387","article-title":"Lower airway inflammation in eosinophilic chronic rhinosinusitis as determined by exhaled nitric oxide","volume":"173","author":"Kambara","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib59","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.anl.2017.07.020","article-title":"Pulmonary function in patients with eosinophilic chronic rhinosinusitis","volume":"45","author":"Uraguchi","year":"2018","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jaip.2020.09.063_bib60","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2020.01.024","article-title":"The sense of smell in chronic rhinosinusitis","volume":"145","author":"Mullol","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.jaip.2020.09.063_bib61","first-page":"S15","article-title":"Subclassification of chronic rhinosinusitis","volume":"123","author":"Han","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.09.063_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fmed.2017.00139","article-title":"Interleukin-13 in asthma and other eosinophilic disorders","volume":"4","author":"Doran","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2020.09.063_bib63","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00405-016-4273-1","article-title":"Aspirin-exacerbated respiratory disease and current treatment modalities","volume":"274","author":"Sakalar","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2020.09.063_bib64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1398-9995.2009.02206.x","article-title":"Elevated urinary leukotriene E excretion in asthma: a comparison of HPLC-mass spectrometry and ELISA","volume":"65","author":"Sanak","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D2: a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2011.01.065","article-title":"Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma","volume":"128","author":"Roca-Ferrer","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib67","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1164\/ajrccm.160.1.9808048","article-title":"Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics","volume":"160","author":"Picado","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.09.063_bib68","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","article-title":"Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis","volume":"115","author":"P\u00e9rez-Novo","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib69","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jaci.2015.10.020","article-title":"Thymic stromal lymphopoietin controls prostaglandin D2 generation in aspirin-exacerbated respiratory disease","volume":"137","author":"Buchheit","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib70","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.4049\/jimmunol.1500905","article-title":"Aspirin-exacerbated respiratory disease involves a cysteinyl leukotriene-driven IL-33-mediated mast cell activation pathway","volume":"195","author":"Liu","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib71","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1165\/rcmb.2014-0486OC","article-title":"Impaired E prostanoid2 expression and resistance to prostaglandin E2 in nasal polyp fibroblasts from subjects with aspirin-exacerbated respiratory disease","volume":"54","author":"Cahill","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaip.2020.09.063_bib72","doi-asserted-by":"crossref","first-page":"e51281","DOI":"10.1371\/journal.pone.0051281","article-title":"Signal transduction pathways (MAPKs, NF-\u03baB, and C\/EBP) regulating COX-2 expression in nasal fibroblasts from asthma patients with aspirin intolerance","volume":"7","author":"Garcia-Garcia","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2020.09.063_bib73","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaci.2015.09.028","article-title":"Low E-prostanoid 2 receptor levels and deficient induction of the IL-1\u03b2\/IL-1 type I receptor\/COX-2 pathway: vicious circle in patients with aspirin-exacerbated respiratory disease","volume":"137","author":"Machado-Carvalho","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.rmed.2019.03.008","article-title":"IL-4\/IFN-\u03b3 inflammatory cytokine profile induces a deficient regulation of the IL-1\u03b2\/IL-1RI\/EP2\/COX-2 pathway in nasal mucosa","volume":"150","author":"Machado-Carvalho","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2020.09.063_bib75","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib76","first-page":"CD006990","article-title":"Surgical interventions for chronic rhinosinusitis with nasal polyps","volume":"11","author":"Sharma","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2020.09.063_bib77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/iid3.46","article-title":"A\u00a0retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men","volume":"3","author":"Stevens","year":"2015","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaip.2020.09.063_bib78","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2013.05.008","article-title":"Prominent role of IFN-\u03b3 in patients with aspirin-exacerbated respiratory disease","volume":"132","author":"Steinke","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib79","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1398-9995.2005.00725.x","article-title":"Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments","volume":"60","author":"Alobid","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib80","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11136-004-1597-x","article-title":"The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis","volume":"14","author":"Alobid","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jaip.2020.09.063_bib81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4193\/Rhin17.255","article-title":"The Global Allergy and Asthma European Network (GALEN) rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps","volume":"57","author":"Khan","year":"2019","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.09.063_bib82","doi-asserted-by":"crossref","first-page":"e6147","DOI":"10.1097\/MD.0000000000006147","article-title":"Impact of nasal symptoms on the evaluation of asthma control","volume":"96","author":"Huang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2020.09.063_bib83","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4193\/Rhino10.295","article-title":"Persistent asthma has an accumulative impact on the loss of smell in patients with nasal polyposis","volume":"49","author":"Alobid","year":"2011","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.09.063_bib84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/lary.24330","article-title":"Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in sino-nasal polyposis","volume":"124","author":"Alobid","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.09.063_bib85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1081-1206(10)62468-4","article-title":"Nasal polyposis: clinical course during 20 years","volume":"65","author":"Vento","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.jaip.2020.09.063_bib86","first-page":"1","article-title":"SEAIC-SEORL. Consensus document on nasal polyposis. POLINA project","volume":"21","author":"Alobid","year":"2011","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib87","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00405-016-4366-x","article-title":"Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study","volume":"274","author":"Gudziol","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2020.09.063_bib88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/alr.22249","article-title":"Patterns of olfactory dysfunction in chronic rhinosinusitis identified by hierarchical cluster analysis and machine learning algorithms","volume":"9","author":"Morse","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.09.063_bib89","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/all.13048","article-title":"Asthma quality of life and control after sinus surgery in patients with chronic rhinosinusitis","volume":"72","author":"Schlosser","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.09.063_bib90","first-page":"323","article-title":"Chronic rhinosinusitis exacerbations are differentially associated with lost productivity based on asthma status","volume":"56","author":"Phillips","year":"2018","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.09.063_bib91","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4193\/Rhin17.029","article-title":"Chronic rhinosinusitis severity is associated with need for asthma-related systemic corticosteroids","volume":"55","author":"Phillips","year":"2017","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.09.063_bib92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11882-018-0776-8","article-title":"Precision medicine in chronic rhinosinusitis with nasal polyps","volume":"18","author":"Avdeeva","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2020.09.063_bib93","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.09.063_bib94","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/MLG.0b013e318170af1e","article-title":"Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma?","volume":"118","author":"Awad","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.09.063_bib95","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1097\/MLG.0b013e3180caa19d","article-title":"Influence of polyps on outcomes after endoscopic sinus surgery","volume":"117","author":"Bhattacharyya","year":"2007","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.09.063_bib96","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2500\/ajr.2007.21.3108","article-title":"Long-term outcome analysis of endoscopic sinus surgery for chronic sinusitis","volume":"21","author":"Young","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaip.2020.09.063_bib97","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jaip.2019.08.007","article-title":"Asthma is the dominant factor for recurrence in chronic rhinosinusitis","volume":"8","author":"Sella","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.09.063_bib98","doi-asserted-by":"crossref","first-page":"102286","DOI":"10.1016\/j.amjoto.2019.102286","article-title":"Predictive markers of long-term recurrence in chronic rhinosinusitis with nasal polyps","volume":"41","author":"Davide","year":"2020","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jaip.2020.09.063_bib99","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/alr.21674","article-title":"Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes","volume":"6","author":"Promsopa","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.09.063_bib102","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.09.063_bib103","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.jaip.2019.03.023","article-title":"Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma","volume":"7","author":"Bachert","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.09.063_bib104","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.09.063_bib105","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.09.063_bib106","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","article-title":"Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis","volume":"158","author":"Hirano","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2020.09.063_bib107","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jaip.2019.03.044","article-title":"Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD","volume":"7","author":"Laidlaw","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"Suppl 63","key":"10.1016\/j.jaip.2020.09.063_bib108","first-page":"PA539","article-title":"Dupilumab (DPL) improves upper and lower airway outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP) with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (NSAID-ERD): pooled results from SINUS-24, SINUS-52 phase 3 trials","volume":"54","author":"Laidlaw","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.09.063_bib109","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: two randomized phase III trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.09.063_bib110","series-title":"Dupilumab improves asthma-related patient reported outcomes in asthma patients with chronic rhinosinusitis or nasal polyposis in the LIBERTY ASTHMA QUEST study. Presented at: 28th Annual Congress of the European Respiratory Society","author":"Corren","year":"2018"},{"key":"10.1016\/j.jaip.2020.09.063_bib111","series-title":"Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polyposis in the LIBERTY ASTHMA QUEST study. Presented at: 28th Annual Congress of the European Respiratory Society","author":"Busse","year":"2018"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820311132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820311132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:25:37Z","timestamp":1761974737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820311132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2213219820311132"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.09.063","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Rhinosinusitis with Nasal Polyps and Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.09.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}